EU seeks feedback on Sanofi's commitments addressing suspected anti-competitive behaviour

CSL

08/07/2026 10:45

BRUSSELS, July 8 (Reuters) - The European Commission said on Wednesday it would seek feedback on commitments offered by French pharmaceutical company Sanofi SASY.PA to address concerns that it may have breached competition rules in a flu vaccine marketing campaign.
The Commission opened an investigation two weeks ago into whether Sanofi had carried out a misleading campaign to sell its "Efluelda" flu vaccine while disparaging a rival one called "Fluad" made by CSL Seqirus CSL.AX, primarily in France and Germany. 
     To address the Commission concerns, Sanofi offered a series of commitments, such as publishing statements on its website,  that would remain in force until 2030. 

 (Reporting by Inti Landauro; editing by Foo Yun Chee)
 ((Inti.Landauro@thomsonreuters.com;))